Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 214.31B | 175.47B | 147.47B | 152.82B | 204.63B |
Gross Profit | 23.68B | 4.24B | 4.61B | 4.50B | 22.69B |
EBITDA | 12.25B | -2.28B | -8.27B | -3.60B | 13.97B |
Net Income | -313.00M | -13.13B | -19.03B | -17.08B | -2.02B |
Balance Sheet | |||||
Total Assets | 142.04B | 148.82B | 142.93B | 145.54B | 150.69B |
Cash, Cash Equivalents and Short-Term Investments | 24.12B | 32.87B | 27.94B | 21.32B | 22.70B |
Total Debt | 74.32B | 79.69B | 71.12B | 60.39B | 47.13B |
Total Liabilities | 119.61B | 127.51B | 111.13B | 98.10B | 85.70B |
Stockholders Equity | 12.36B | 11.28B | 22.33B | 38.66B | 55.99B |
Cash Flow | |||||
Free Cash Flow | -4.26B | -5.39B | -3.71B | -14.29B | -6.21B |
Operating Cash Flow | -547.00M | -1.90B | 2.07B | -4.22B | 6.88B |
Investing Cash Flow | 871.00M | 2.74B | -3.60B | -7.54B | -11.95B |
Financing Cash Flow | -10.74B | 2.34B | 6.24B | 10.27B | 8.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥116.75B | 9.87 | 3.69% | 1.71% | -11.98% | ||
78 Outperform | ¥17.54B | 7.96 | 2.62% | -7.01% | -108.77% | ||
66 Neutral | ¥92.91B | 13.99 | 3.12% | 0.60% | 172.55% | ||
66 Neutral | ¥4.27B | 7.42 | 4.10% | 4.93% | ― | ||
63 Neutral | £1.72B | 10.20 | 4.37% | 3.49% | 0.66% | -38.91% | |
61 Neutral | ¥7.82B | 56.94 | 3.67% | -2.95% | -97.72% | ||
39 Underperform | ¥4.06B | ― | ― | 33.86% | 69.12% |